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1. Introduction
Emerging evidence suggests that gut microbiota play an 
important role in human health. It is reported that almost 
100 trillion microorganisms reside in the intestinal tract. 
Among these, most are bacteria but they may also include 
archaea and fungi. This microbiota has been selected 
through long-term co-evolution along with the host, and 
therefore they are involved in numerous physiological 
processes of the host. Dysbiosis of the microbiota is 
associated with the pathogenesis of several disorders, 
including inflammatory bowel disease (IBD), obesity and 
cardiovascular disease (Blumberg et al., 2012; Hviid et al., 
2011; Ridaura et al., 2013). Recent studies have suggested 
that the gut microbiota could affect the behaviour of hosts 
and implicated their involvement in depression, anxiety-like 
behaviours, and in modulating the hypothalamic-pituitary-
adrenal axis (HPA-axis) (Barouei et al., 2012; Collins et al., 
2012; Cryan and Dinan, 2012; Tillisch et al., 2013).
The composition of gut microbiota is constantly affected 
by antibiotics, which are routinely administered to treat 
various infections (Cho et al., 2010; Jernberg et al., 2010; 
Pérez-Cobas et al., 2012). Clinical research has shown 
that antibiotics induce diarrhoea (Alam and Mushtaq, 
2009) in children and older patients, and could even cause 
IBD. These antibiotic-induced changes lead to immunity 
disorder, and increases susceptibility to infection and impair 
the host immune system (Sekirov et al., 2008; Hviid et al., 
2011; Nutten et al., 2007). Bercik et al. (2011a,b) reported 
that a mixture of three antibiotics, neomycin, bacitracin, 
and pimaricin, induced exploration behaviour in mice 
similar to the behaviour of germ-free mice (Heijtz et al., 
2011). However, these three antibiotics are not routinely 
used in clinics.
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Abstract
Gut microbiota play a vital role in maintaining the health of the host. Many factors affect gut microbiota; application 
of broad range antibiotics disturb microbiota, while probiotic application protects the microbiota. To investigate 
how probiotics alter the physiological and psychological changes induced by antibiotics, we tested the performance 
of ampicillin-treated rats in the presence or absence of Lactobacillus fermentum strain NS9, in elevated plus maze 
and Morris water maze. The results showed that NS9 normalised the composition of gut microbiota and alleviated 
the ampicillin-induced inflammation in the colon. The levels of the mineralocorticoid and N-methyl-D-aspartate 
receptors were also elevated in the hippocampus of the ampillicin+NS9 treated group. NS9 administration also 
reduced the anxiety-like behaviour and alleviated the ampicillin-induced impairment in memory retention. 
These findings suggest that NS9 is beneficial to the host, because it restores the physiological and psychological 
abnormalities induced by ampicillin. Our results highlight how gut contents regulate the brain, and shed light on 
the clinical applications of probiotics to treat the side effect of antibiotics and mental disorders.
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When applied in adequate amounts probiotics are beneficial 
to the host; they improve the colonic barrier function 
impaired by early-life stress and have been used to treat 
many illnesses such as diarrhoea, IBD, and other gut 
disorders (Floch et al., 2011). Administration of probiotics 
has been reported to modulate the gut microbiota (Lyra 
et al., 2010) and regulate the HPA axis activity in the 
neonatal maternal separation model (Gareau et al., 2007). 
In addition, various probiotic strains have been shown to 
reduce the anxiety-like behaviour induced by the intestinal 
inflammation in animal models and clinical trials (Bercik et 
al., 2010; Bravo et al., 2011; Gareau et al., 2011; Messaoudi 
et al., 2011). They also improve memory defects induced by 
bacterial infection and stress (Gareau et al., 2011).
Although a number of studies have investigated the gut-
microbiome-brain connection, the effects of antibiotics on 
learning and memory behaviour are not well understood. 
Therefore, in this study we determined whether clinical 
antibiotics can induce anxiety-like behaviour and 
hippocampal dependent spatial memory in rats, and whether 
the application of probiotics can provide protection. We 
treated rats with ampicillin in the presence or absence of 
Lactobacillus fermentum strain NS9, and analysed anxiety-
like behaviour, spatial learning and memory behaviour 
using the elevated plus maze and Morris water maze. The 
gut microbiota composition, colon inflammation and brain 
biochemistry were also assessed. Our results suggest that 
L. fermentum NS9 can normalise the intestinal microbiota, 
as well as the anxiety-like behaviour and spatial memory 
defects induced by antibiotics. These findings shed light 
on the mechanism behind the clinical use of probiotics 
along with antibiotics during the treatment of an infection.
2. Materials and methods
Animal
All animal experimentation was performed according to 
the guidelines for the care and use of laboratory animals 
approved by Institute of Psychology, Chinese Academy 
of Sciences. Thirty weaned male Sprague-Dawley rats 
(Rattus norvegicus) were purchased from the Vital 
River Laboratories Co., Ltd. (Beijing, China P.R.). Rats 
were housed individually in wire-mesh cages in a special 
pathogen free environment, with 50% relative humidity, 
a temperature of 21±1 °C and on a 12 h light-dark cycle 
(light from 7:00 PM to 19:00 AM) with free access to food 
and water.
qPCR
Fresh faecal samples were collected from the rats on the 
day 0 and 41 day after initiating the antibiotic or probiotic 
treatment (Figure 1), and frozen at -20 °C. Bacterial DNA 
was isolated from the faeces using a stool kit (Tiangen 
Biotech Co. Ltd., Beijing, China P.R.) following the 
manufacturer’s instructions. The bacterial 16S rRNA was 
amplified by qPCR using SYBR® Premix Ex Taq™ (Takara, 
Japan) on an ABI 7300 (Applied Biosystems, Carlsbad, 
CA, USA). Relative expression levels were calculated 
using the 2-ΔΔCT method (Livak and Schmittgen, 2001). 
Relative levels of the gut microbiota including Bacteroides, 
Clostridium coccoides, Firmicutes and Lactobacillus to 
Eubacteria (all bacteria) were measured from the 16S rRNA 
expression levels using species specific primers (Table 1). 
The results are expressed as percentage expression of each 
species relative to all bacteria (Gareau et al., 2011).
Probiotic treatment
L. fermentum strain NS9 (laboratory designated numbers) 
was isolated from naturally fermented dairy products 
collected from grasslands in Inner Mongolia, China P.R. The 
genome of this strain was sequenced (1,502 bp) and given 
the following unique GenBank accession no. JQ013298.1. 
Previous reports have shown that L. fermentum could 
modulate gut microbiota or prevent antibiotics induced 
side effects in gut (Axling et al., 2012; Lönnermark et al., 
2010). The NS9 strain was incubated in De Man, Rogosa 
and Sharpe (MRS) broth at 37 °C overnight, collected by 
centrifugation at 3000 rpm for 10 min, and washed twice 
in saline (0.9% NaCl). The pellet was then re-suspended 
in sterile water and added to the drinking water for rats at 
a concentration of 109 cfu/ml. This water was provided to 
the rats and was changed every day.
Experimental design
After one week of acclimatisation, the rats were assigned 
to the following three groups. All groups were provided 
with identical food but with different drinking water as 
described below:
MWM
EPM Experiment 1 Experiment 2
Training Training
Test 1 Test 2 Test 3
Ampicillin/ampicillin with Lactobacillus
Day
-7 1 31 32 35 36 37 38 39 41
Figure 1. Schematic representation of the experimental design 
conducted in this study. After one week of acclimatisation, 
the rats were fed on water, ampicillin, or ampicillin with 
Lactobacillus fermentum NS9 for 41 days. From day 31, 
behavioural tests, including elevated plus maze (EPM) and 
Morris water maze (MWM), were carried out.
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1.  Control group (n=10) was given regular drinking water;
2.  Amp group (n=10) received ampicillin (Genview, Naples, 
FL, USA) at the concentration of 120 mg/kg body weight 
added to the drinking water;
3.  Amp+NS9 group (n=10) received L. fermentum NS9 
and ampicillin. NS9 and ampicillin was added to the 
drinking water at a concentration of 109 cfu/ml and 120 
mg/kg body weight, respectively.
In order to avoid the adverse effects of ampicillin on NS9 
we used the following approach. In the Amp+NS9 group, 
every day ampicillin was added to the drinking water at 7:00 
AM and the water was changed at 19:00 PM with water 
containing NS9. Similarly, in the Amp group ampicillin 
was added to the drinking water at 7:00 AM and the water 
was changed at 19:00 PM with regular drinking water. This 
ensured that the ampicillin consumption was similar in the 
Amp and Amp+NS9 groups. The drinking water that had 
been removed from each group every day was analysed 
to calculate the amounts of ampicillin and NS9 based on 
the water consumption. The drinking water was changed 
every day. On average 8-10 ml water was consumed per 
100 g rat body weight per day (Hu et al., 2013). Treatment 
with probiotics and/or ampicillin was continued for 41 
days after which the rats were sacrificed.
Rats were tested for behaviour 30 days after initiation of the 
antibiotic or probiotic treatment. For behavioural analysis, 
the rats were transferred to the test room to habituate to 
the new environment. On the day 31, an elevated plus maze 
test was performed followed by the Morris water maze on 
the next day. The water maze had two phases, experiment 
1 was conducted from day 32 to 36 and experiment 2 was 
conducted from day 37 to 41. On the day 41 the rats were 
sacrificed.
Myeloperoxidase activity
Acute inflammation was assessed by myeloperoxidase 
(MPO) activity in the colon. About 1 cm long colon 
segments were dissected from the rats and gently cleaned 
with phosphate buffered saline (PBS), after which they 
were immediately frozen in liquid nitrogen and stored at 
-80 °C. The MPO activity assay was performed on frozen 
tissue as described by Boughton-Smith et al. (1988). MPO 
activity was expressed in units per mg of tissue, where one 
unit of MPO is defined as the quantity of enzyme able to 
convert 1 mol of hydrogen peroxide to water in 1 min at 
room temperature.
Behavioural tests
Two behavioural tests were used in this study, the elevated 
plus maze and the Morris water maze.
The elevated plus maze
The maze had two open arms (50×10 cm) and two closed 
arms of the same size and the closed arm had 25 cm high 
walls. The whole maze was at a height of 50 cm from the 
floor. All testing were conducted during the mid-portion 
of the light phase. The rats were placed individually in the 
central zone of the maze, facing an open arm, and allowed 
5 min to explore freely. Animal behaviour was recorded by 
a video camera positioned at the top centre of the maze. 
The maze was thoroughly cleaned after each test using 
damp and dry cloths. All rats were tested once. The total 
distance travelled and number of arm entries was recorded 
as an index of general locomotor activity. The percentage 
of open arm entries (defined as four paws inside the maze 
arm) was quantified as a measure of anxiety-like behaviour 
(Anseloni et al., 1999; Sharma et al., in press).
Table 1. Primer sequences used in qPCR to analyse the faecal microbiome.
Name of primer Sequence (5’-3’) Target species Annealing temp. (°C) Reference
Lact-F CGATGAGTGCTAGGTGTTGGA Lactobacillus 61 Fu et al. (2006)
Lact-R CAAGATGTCAAGACCTGGTAAG
Bac-F GAGAGGAAGGTCCCCCAC Bacteroides 58 Gareau et al. (2011)
Bac-R CGCTACTTGGCTGGTTCAG
Fir-F GGAGYATGTGGTTTAATTCGAAGCA Firmicutes 60 Guo et al. (2008)
Fir-R AGCTGACGACAACCATGCAC
Clos-F ACTCCTACGGGAGGCAGC Clostridium 60 Gareau et al. (2011)
Clos-R GCTTCTTAGTCAGGTACCGTCAT
Eu-F ACTCCTACGGGAGGCAGCAGT Total bacteria 60 Gareau et al. (2011)
Eu-R ATTACCGCGGCTGCTGGC
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The Morris water maze
The water maze pool (160 cm in diameter and 40 cm high) 
was filled with water (21±2° °C) to a height of 30 cm. Four 
distinctive landmarks approximately 20×20 cm in size were 
also placed at heights of 50 cm from the water surface. A 
movable circular platform (12 cm in diameter) placed 2 cm 
below the water surface served as an escape platform. A 
camera was mounted above the centre of the pool at a height 
of 2.1 m above the floor. The swimming speed, distance and 
latency to the escape platform were monitored through a 
computer based image analysis system (ANYmaze; Stoelting 
Co., Wood Dale, IL, USA). For analysis, the pool was 
subdivided into 4 equal quadrants (NE, SE, NW, and SW).
In Phase 1, the platform was placed in the SW quadrant. 
Rats were released from 4 symmetrical positions in a 
pseudo-randomised order so that the average distance of the 
starting position from the platform in 4 consecutive trials 
was same. Animals had four trials per day (separated by 15 
min), for four consecutive days (day 32 to 35). Each trial 
lasted for 120 s. If a rat failed to find the platform during 
the time, it was guided to it. Rats were allowed to stay on 
the platform for 20 s. A probe trial was performed on the 
day 36. The platform was removed, and rats were allowed 
to swim for 120 s. The swimming speed, distance, latency 
to the platform and the time spent in the 4 quadrants were 
recorded.
Phase 2 started on day 37. The platform was placed in the 
NE quadrant, opposite to the previous position. The rats 
were trained for 2 days from day 37 to 38, with 3 trials per 
day with an interval of 15 min between the trials (Figure 1). 
On day 39 and 41, the platform was removed and the tests 
were carried out. The swimming speed, distance, latency 
to the platform and the time spent in each quadrant were 
recorded.
Corticosterone
HPA axis activity was assessed by measuring the 
corticosterone (CORT) level in rat serum (Oprica et al., 
2005). After the Morris water maze test, the rats were 
sacrificed and the trunk blood was collected. The blood 
samples were centrifuged at 2,000 rpm for 10 min at 4 °C 
and the isolated serum samples were frozen at -80 °C 
until further analysis. CORT level was measured using a 
commercial ELISA kit (IBL, Hamburg, Germany) and the 
results were recorded using a microplate reader (Labsystems 
Multiskan MS, Nelsirrki, Finland). The results are presented 
as ng/l.
Brain sample preparation
After sacrifice, the rat brains were removed immediately 
and the hippocampuses were isolated on ice. The samples 
were homogenised in PBS (pH 7.4) and the homogenate 
was centrifuged at 2,000 rpm for 20 min at 4 °C. The 
brain derived neurotrophic factor (BDNF), N-methyl-
D-aspertate (NMDA), glucocorticoid receptor (GR) and 
mineralocorticoid receptor (MR) levels were measured 
with commercial ELISA kits (DRG, Springfield, NJ, 
USA) following the procedures recommended by the 
manufactures.
Statistical analysis
Results are expressed as mean ± standard error (SE). Non-
parametric statistics (Mann Whitney U-test) was used to 
analyse the gut microbiota data. In other tests, groups 
were compared by analysis of variance (ANOVA) using 
SPSS 17.0 (SPSS Inc., Chicago, IL, USA). Post hoc analysis 
(Bonferroni or Student-Newman-Leuls) were performed, 
as indicated. P-values of <0.05 and <0.01 were considered 
significant and extremely significant, respectively.
3. Results
Effects of Lactobacillus fermentum on rat gut microbiota
Data obtained from qPCR indicated that similar levels of 
Bacteroides, C. coccoides, Firmicutes, and Lactobacillus 
(P>0.05) were observed in all three groups before ampicillin 
or L. fermentum NS9 administration (Figure 2A). Mann 
Whitney U-test analysis suggested that, compared to the 
control group, ampicillin administration led to a significant 
reduction in Bacteroides and Lactobacillus (P<0.01), and a 
remarkable increase in C. coccoides and Firmicutes, which 
were significantly higher than the control group (P<0.01, 
Figure 2B). In the Amp+NS9 group, Bacteroides was similar 
to the control rats (P>0.05). Compared to the ampicillin 
treated rats, the level of Firmicutes and C. coccoides was 
reduced significantly by NS9 application (P<0.01, Figure 
2B). NS9 application also increased the level of Lactobacillus 
by 20%, which was significantly higher than the control rats 
and ampicillin treated rats (P<0.01, Figure 2B).
Effect on myeloperoxidase activity by Lactobacillus 
fermentum
Ampicillin treatment is known to induce colon 
inflammation. As shown in Figure 3, in contrast to the 
control group (4.3±0.9 U/mg), colon tissue in the ampicillin 
treated group had higher MPO activity (6.7±1.1 U/mg, 
P<0.05), which reduced to the normal value (5.0±1.1 U/
mg, P<0.05) after L. fermentum NS9 treatment (P>0.05).
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Effect of Lactobacillus fermentum on ampicillin induced 
anxiety-like behaviour in rats
Ampicillin treatment did not change the locomotor activity, 
which was shown by the total distance travelled (Figure 
4A) and total arm entries by the rats (Figure 4B). However, 
it induced a mild anxiety-like behaviour. Compared to 
control rats, ampicillin treated rats showed an obvious 
decrease in the percentage of open-arm entries and increase 
in the closed-arm entries. Treatment with L. fermentum 
NS9 alleviated this abnormal behaviour and elevated the 
percentage of open arm entries and reduced the percentage 
of close arm entries (P<0.05). However, there was no 
significant difference in the time spent in the open arm 
or closed arm between the Amp and control groups (data 
not shown).
Effect of Lactobacillus fermentum treatment on ampicillin 
induced spatial memory impairment
The Morris water maze test was carried out for 10 days 
in 2 phases to evaluate the effects of ampicillin and NS9 
on spatial learning and memory. In phase 1 (day 32 to 
36), the control group exhibited shorter latency than the 
Amp and Amp+NS9 groups (Figure 5A) on the first day 
of training. This demonstrated that ampicillin marginally 
impaired the learning behaviour, which was not alleviated 
by NS9 application. The difference between the three 
groups gradually diminished over time. Until the 4th day 
(treatment day 35), the three groups had similar latency to 
find the platform. On the 5th day (treatment day 36) when 
the platform was removed in test 1 all rats in the three 
groups spent a similar amount of time in the platform 
quadrant (Figure 5B) indicating that all rats remembered 
the location of the platform.
In phase 2, the platform was removed to the opposite 
quadrant (NE) to allow the rats to learn the new position 
of the platform. Figure 6A shows that the latency of control 
rats was evidently shorter than the ampicillin treated rats, 
and the NS9 application did not reduce the latency to the 
control level. This suggested that learning of rats fed on 
ampicillin was slower than the control rats. After 6 trials 
we observed that the rats in the three groups had a similar 
latency to the escape platform. On day 39, the platform was 
removed and the rats were subjected to the 2nd probe test. 
As shown in Figure 6B, control and Amp+NS9 treated rats 
spent most of their time in two quadrants; the quadrant 
where the platform was previously located and the new 
quadrant which contained the platform. This indicated that 
the rats in these two groups remembered the two locations 
of the escape platform (Figure 6B). But the ampicillin treated 
rats spent nearly equal times in all 4 quadrants suggesting 
that ampicillin treated rats did not only forget the new 
location but also forgot the previous location.
























































Figure 2. (A) The composition of gut microbiota in rat faeces before treatment with ampicillin (Amp) and Lactobacillus fermentum 
NS9 (NS9). (B) The composition of gut microbiota in rat faeces at the end of the experiment. Bac = Bacteroides; Clos = Clostridium 
coccoides; Fir = Firmicutes; Lac = Lactobacillus. * P<0.05, compared to the control; # P<0.05, significant differences between 






















Figure 3. The effect of Lactobacillus fermentum NS9 and 
ampicillin (Amp) on myeloperoxidase (MPO) activity in the rat 
colon. Each group consisted of 10 rats. * P<0.05, compared 
to the control group. 
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To investigate the ampicillin effects on long term memory, 
the probe test was repeated again after two days (test 3 
in Figure 1). There were significant differences among 
the three groups. As shown in Figure 6C, the ampicillin 
treated rats still spent equal times (25%) in the 4 quadrants. 
However, the control and the NS9 treated rats spent 
(nearly 35 and 30%, respectively) significantly more time 
in quadrant SW, which previously contained the platform, 
than the ampicillin treated rats (P<0.05). This result shows 
that NS9 application significantly alleviated the memory 
defects induced by ampicillin. All rats in the three groups 
forgot the new location indicating that 6 trials were not 
enough to maintain the location memory for 72 h.
Effect of Lactobacillus fermentum on serum 
corticosterone
Ampicillin application markedly elevated serum cortico-
sterone levels (from 550 to710 ng/l). Treatment with L. 
fermentum NS9 restored corticosterone levels to similar 








































































Figure 4. Anxiety-like behaviour of rats treated with ampicillin (Amp) and Lactobacillus fermentum NS9 in the elevated plus maze. 
(A) Total distance travelled; (B) number of total arm entries; (C) percentage open arms entries; and (D) percentage of closed 
arm entries. * P<0.05, compared to control group rats. # P<0.05, comparison between groups using one-way ANOVA followed by 
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Figure 5. Rat performance in phase 1 of the Morris water maze test. (A) Escape latency to find platform in experiment 1. Each 
block represents mean of four trials. Values are means ± standard error. *P<0.05, compared to control group. (B) Percentage of 
time spent in the 4 quadrants. Values are means ± standard error. *P<0.05, the target quadrant compared to other quadrants. The 
platform was located in target quadrant SW. There were 10 rats in each group. Control = untreated; Amp = ampicillin treated; NS9 
= Lactobacillus fermentum NS9 treated.
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Effect of Lactobacillus fermentum on BDNF, NMDA, MR 
and GR levels
The level of BDNF in the hippocampus was not different 
between the groups. As shown in Figure 8A, neither 
ampicillin application nor NS9 application changed the 
levels of BDNF in the hippocampus.
Two kinds of corticosterone receptors, MR and GR, have 
been reported in the hippocampus, which is the main 
target of corticosterone. Treatment with ampicillin and 
NS9 had no effect on GR levels (Figure 8B). However, 
ampicillin administration significantly reduced MR levels 
(P<0.05). Such a decrease was not observed in the NS9 
treated group, which had remarkably increased levels of 
MR, when compared to control rats (P<0.05, Figure 8C). 
Ampicillin also significantly reduced the NMDA receptor 
levels from 1,249±299 to 835±127 ng/g tissue. Treatment 
with NS9 inhibited the ampicillin induced NMDA receptor 
reduction and maintained it at the normal level (1,192±176 
ng/g tissue) (Figure 8D).
4. Discussion and conclusion
Gut microbiota are known to have a critical function 
in the overall health of an individual. Since intake of 
antibiotics is known to disturb microbiota and probiotics 
are routinely prescribed along with antibiotics to protect 
the microbiota, we performed this study to investigate 
how ampicillin alters the gut microbiome and whether 
probiotics can restore the antibiotic induced changes in 
or outside the gut. The results of our study suggested that 
treatment with ampicillin affected gut physiology, as well as 
emotional and spatial memory behaviour of male SD rats. 
NS9 application ameliorated the colon inflammation and 
normalised the emotional behaviour and spatial memory 
deficits induced by ampicillin. Furthermore, the efficiency 
of NS9 was associated in part, with the restoration of serum 
corticosterone level and the hippocampus MR and NMDA 
receptor levels in the normalised gut microbiota.
The microbiota-gut-brain axis, which is the line of 
interaction between the gut microbiota, gut and brain, 
plays an important role in maintaining the gut and brain 
function. Many factors that induce changes in the intestinal 
microbiota could also induce gut or brain disability, such 
as IBD (Hviid et al., 2011), anxiety-like behaviour (Bercik 
et al., 2010) or memory and learning alteration (Gareau 
et al., 2011; Li et al., 2009). In this study, treatment with 
ampicillin induced marked changes in the intestinal 
microbiota composition as evidenced by a decrease in 
Lactobacillus and Bacteroides levels and an increase in 
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Figure 6. Rat performance in the second phase of Morris water maze. (A) Latency to find platform in every trial during training 
stage. Values are mean ± standard error. * P<0.05, compared to control group. (B) Percentage time spent in the 4 quadrants in 
probe test 2 after 24 h (day 39). Values are mean ± standard error. * P<0.05, other quadrants versus the target quadrant  NE. (C) 
Percentage time spent in the 4 quadrants in probe test 3 after 72 h (day 41). Values are mean ± standard error. * P<0.05, other 



















Figure 7. Serum corticosterone levels in rats treated with 
ampicillin (Amp) and Lactobacillus fermentum NS9. * P<0.05, 
compared to the control group.
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improved the composition of the gut microbiota and 
alleviated the anxiety-like behaviour, and memory and 
learning behaviour. These findings highlight the role of 
the gut microbiota on behaviour.
Previous studies have shown that application of probiotics 
increase the gut immune response (Palomar et al., 2013) and 
ameliorate colonic dysfunction induced by stress (Gareau 
et al., 2007). In these reports, gut microbiota composition 
was also improved by probiotic treatment. The observed 
reduction in inflammation caused by NS9 application in 
our study may be associated with the restoration of gut 
microbiota by NS9. Emerging clinical and animal studies 
suggest that gut inflammation is associated with emotional 
behaviour (Bercik et al., 2010; Stasi and Orlandlli, 2008). 
We used MPO activity as a measure to monitor mucosal 
inflammation induced by antibiotic treatment (Bercík et al., 
2004). The reduced MPO activity in NS9 treated rats could 
be at least in part, attributed to the alleviated anxiety-like 
behaviour in these rats.
Dysbiosis of the microbiota is known to affect the HPA 
axis activity (Sudo et al., 2004). Dysfunction in the HPA 
axis in turn has been linked to the development of mood 
disorders. In this study, L. fermentum NS9 administration 
reduced higher serum corticosterone level and ameliorated 
the anxiety like behaviour induced by the treatment of 
ampicillin. These results are consistent with previous 
reports that showed elevated corticosterone levels 
associated with anxiety like behaviour (Kalinichev et 
al., 2002; Kallen et al., 2008; Mitra and Sapolsky, 2008). 
This result also suggested that the behavioural effect of 
Lactobacillus was at the physiological level.
Corticosterone levels and expression of GR and MR 
receptors in the brain are essential for learning and memory 
(Brinks et al., 2007; Yau et al., 1995). In the rat brain, 
hippocampus is the main target of corticosterone, with 
high expression levels of MR and GR (Reul and De Kloet, 
1985). Genetic and pharmacological studies have implicated 
a key role for MR and GR in learning and memory. MR 
protects the neuron and is involved in the hippocampal 
neurogenesis (Gass et al., 2000; Holsboer et al., 1983). We 
observed that ampicillin administration did not impair 
learning seriously. All rats showed steady improvement 
across trials, as reflected by decreased latency to find the 
platform regardless of the treatment. Both central MR 
antagonism (Yau et al., 1999) and loss of forebrain MR 
(Berger et al., 2006) have been reported to impair memory, 
particularly in spatial memory retention tests. In addition, 
MR over-expression in the forebrain has been shown to 
enhance memory and improve spatial memory retention 
(Lai et al., 2007). In this study, treatment with ampicillin 
reduced MR levels in the hippocampus and the rats failed 
to show quadrant preference similar to rats in the other 
two groups, suggesting that ampicillin impaired memory by 
reducing MR in the hippocampus. When rats were treated 
with NS9, the hippocampal MR levels increased along with 
the recovery of quadrant preference (Figure 6B). These 







































































Figure 8. (A) Brain derived neurotrophic factor (BDNF), (B) glucocorticoid receptor (GR), (C) mineralocorticoid receptor (MR) and 
(D) N-methyl-D-aspertate (NMDA) protein levels in rat hippocampus treated by ampicillin (Amp) and Lactobacillus fermentum NS9. 
* P<0.05, compared to the control group. # P<0.05, differences between groups. Each group consisted of 10 rats.
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impaired memory retention in part, by reducing the MR 
levels in the hippocampus.
The NMDA receptor is a ligand-gated ion channel of 
glutamate essential for long-term potentiation and 
hippocampal-dependent spatial learning and memory 
(Villarreal et al., 2002). It has been reported that NMDA 
receptor interacts with MR and GR to modulate memory 
(Maggio and Segal, 2012). NS9 administration elevated 
the expression of MR and NMDA receptors in our study. 
Animals fed on NS9 showed an enhanced memory of the 
first platform location compared to ampicillin treated 
rats. These findings are consistent with data generated 
by genetically blocking the NMDA receptor in the 
hippocampus dentate gyrus CA1 measured by radial maze 
(Niewoehner et al., 2007; Tsien et al., 1986). Our study 
highlights the importance of this receptor in the memory.
Previous reports have indicated that gut bacteria may 
also influence NMDA receptor and BDNF levels in the 
hippocampus (Sudo et al., 2004). However, in the present 
study, NS9 administration elevated the NMDA receptor 
expression, but not the BDNF level, which is not consistent 
with previous reports (Gareau et al., 2011). This implies that 
probiotic effects are strain dependent and could function 
in different ways. For example, a strain of Bifidobacterium 
infantis did not have anti-depressant properties but affected 
central neurochemical functions and crucial systems 
(Desbonnet et al., 2008). These results suggest that the 
clinical use of probiotics must be performed with caution, 
and more animal and clinical research is needed to address 
this issue.
Previous studies have shown that administering a mixture of 
three antibiotics could change mice behaviour and central 
biochemical levels (Bercik et al., 2011a,b). Our results in 
the present study suggested that even one antibiotic, which 
is considered as safe and have less adverse effects, could 
induce gut microbiota dysbiosis and behaviour abnormality. 
NS9, a strain of Lactobacillus fermentum, isolated in our 
laboratory alleviated these disabilities. We fed rats with 
probiotics and antibiotics almost simultaneously (rats were 
treated with antibiotic during the day and with probiotic 
at night respectively, which protected the probiotic from 
the antibiotic) similar to the study by Dai et al. (2013). This 
method varies from probiotic application prior to stress 
treatment (Gareau et al., 2011) or after stress treatment 
(Bercik et al., 2010), it protects the probiotic activity from 
destruction by the antibiotic and is more practical in clinical 
applications to reduce the side effect of antibiotic. However, 
a limitation of this study is the measurement of the total 
levels of NMDA receptor and MR in the hippocampus, 
as the levels of these receptors were not examined in the 
subfields of hippocampus.
In conclusion, NS9 is beneficial because it restores 
ampicillin induced physiological and psychological 
abnormalities in rats. Our data provide a basis to further 
investigate the utility of probiotics in the maintenance of 
brain health and adjunctive treatment of adverse effects 
induced by clinical antibiotic application.
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